OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat
Sergio Pinar‐Sueiro, José Ángel Zorrilla Hurtado, Patricia Veiga‐Crespo, et al.
Experimental Eye Research (2013) Vol. 110, pp. 55-58
Closed Access | Times Cited: 40
Sergio Pinar‐Sueiro, José Ángel Zorrilla Hurtado, Patricia Veiga‐Crespo, et al.
Experimental Eye Research (2013) Vol. 110, pp. 55-58
Closed Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
Medical Use of Cannabinoids
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 231
Ana Isabel Fraguas‐Sánchez, Ana Isabel Torres‐Suárez
Drugs (2018) Vol. 78, Iss. 16, pp. 1665-1703
Closed Access | Times Cited: 231
Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update
Ru Hui Sim, Srinivasa Rao Sirasanagandla, Srijit Das, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 534-534
Open Access | Times Cited: 46
Ru Hui Sim, Srinivasa Rao Sirasanagandla, Srijit Das, et al.
Nutrients (2022) Vol. 14, Iss. 3, pp. 534-534
Open Access | Times Cited: 46
The Endocannabinoid System as a Therapeutic Target in Glaucoma
Elizabeth A. Cairns, William H. Baldridge, Michael E. Kelly
Neural Plasticity (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 61
Elizabeth A. Cairns, William H. Baldridge, Michael E. Kelly
Neural Plasticity (2016) Vol. 2016, pp. 1-10
Open Access | Times Cited: 61
Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration
Pedro Lax, Gema Esquiva, Cesare Altavilla, et al.
Experimental Eye Research (2014) Vol. 120, pp. 175-185
Closed Access | Times Cited: 60
Pedro Lax, Gema Esquiva, Cesare Altavilla, et al.
Experimental Eye Research (2014) Vol. 120, pp. 175-185
Closed Access | Times Cited: 60
TRPA1 mediates damage of the retina induced by ischemia and reperfusion in mice
Daniel Souza Monteiro de Araújo, Francesco De Logu, Chiara Adembri, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 46
Daniel Souza Monteiro de Araújo, Francesco De Logu, Chiara Adembri, et al.
Cell Death and Disease (2020) Vol. 11, Iss. 8
Open Access | Times Cited: 46
Cannabinoids in Glaucoma Patients: The Never-Ending Story
Andrea Passani, Chiara Posarelli, Angela Tindara Sframeli, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3978-3978
Open Access | Times Cited: 38
Andrea Passani, Chiara Posarelli, Angela Tindara Sframeli, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3978-3978
Open Access | Times Cited: 38
Therapeutic Potential of Cannabinoids in Glaucoma
Theresa Lindner, Doreen Schmidl, Laura Peschorn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1149-1149
Open Access | Times Cited: 12
Theresa Lindner, Doreen Schmidl, Laura Peschorn, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 8, pp. 1149-1149
Open Access | Times Cited: 12
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain
Jean‐François Bouchard, Christian Casanova, Bruno Cécyre, et al.
Neural Plasticity (2015) Vol. 2016, pp. 1-14
Open Access | Times Cited: 36
Jean‐François Bouchard, Christian Casanova, Bruno Cécyre, et al.
Neural Plasticity (2015) Vol. 2016, pp. 1-14
Open Access | Times Cited: 36
Cannabinoids and the eye
Michael T.M. Wang, Helen V. Danesh‐Meyer
Survey of Ophthalmology (2020) Vol. 66, Iss. 2, pp. 327-345
Closed Access | Times Cited: 28
Michael T.M. Wang, Helen V. Danesh‐Meyer
Survey of Ophthalmology (2020) Vol. 66, Iss. 2, pp. 327-345
Closed Access | Times Cited: 28
Cannabinoids as Multitarget Drugs for the Treatment of Autoimmunity in Glaucoma
Lakshmi PK, Rajesh Singh Pawar, Yogesh Kumar Katare, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Lakshmi PK, Rajesh Singh Pawar, Yogesh Kumar Katare, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Role of Endocannabinoids in Glaucoma: A Review
Tanuj Dada, Dewang Angmo, Thirumurthy Velpandian, et al.
JOURNAL OF CURRENT GLAUCOMA PRACTICE (2025) Vol. 19, Iss. 1, pp. 28-37
Open Access
Tanuj Dada, Dewang Angmo, Thirumurthy Velpandian, et al.
JOURNAL OF CURRENT GLAUCOMA PRACTICE (2025) Vol. 19, Iss. 1, pp. 28-37
Open Access
Mouse retinal ganglion cell signalling is dynamically modulated through parallel anterograde activation of cannabinoid and vanilloid pathways
Andrew Jo, Jennifer Noel, Mónika Lakk, et al.
The Journal of Physiology (2017) Vol. 595, Iss. 20, pp. 6499-6516
Open Access | Times Cited: 33
Andrew Jo, Jennifer Noel, Mónika Lakk, et al.
The Journal of Physiology (2017) Vol. 595, Iss. 20, pp. 6499-6516
Open Access | Times Cited: 33
Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia
Daniel Souza Monteiro de Araújo, Vivian Sayuri Miya-Coreixas, Pablo Pandolfo, et al.
Experimental Eye Research (2016) Vol. 154, pp. 116-125
Closed Access | Times Cited: 27
Daniel Souza Monteiro de Araújo, Vivian Sayuri Miya-Coreixas, Pablo Pandolfo, et al.
Experimental Eye Research (2016) Vol. 154, pp. 116-125
Closed Access | Times Cited: 27
The endocannabinoid 2-arachidonoylglycerol and dual ABHD6/MAGL enzyme inhibitors display neuroprotective and anti-inflammatory actions in the in vivo retinal model of AMPA excitotoxicity
Despina Kokona, Dimitris Spyridakos, Manolis Tzatzarakis, et al.
Neuropharmacology (2021) Vol. 185, pp. 108450-108450
Closed Access | Times Cited: 21
Despina Kokona, Dimitris Spyridakos, Manolis Tzatzarakis, et al.
Neuropharmacology (2021) Vol. 185, pp. 108450-108450
Closed Access | Times Cited: 21
Seeing over the horizon – targeting the endocannabinoid system for the treatment of ocular disease
Elizabeth A. Cairns, James Thomas Toguri, Richard F. Porter, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 253-265
Closed Access | Times Cited: 27
Elizabeth A. Cairns, James Thomas Toguri, Richard F. Porter, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2015) Vol. 27, Iss. 3, pp. 253-265
Closed Access | Times Cited: 27
TheIn VivoEffects of the CB1-Positive Allosteric Modulator GAT229 on Intraocular Pressure in Ocular Normotensive and Hypertensive Mice
Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex Straiker, et al.
Journal of Ocular Pharmacology and Therapeutics (2017) Vol. 33, Iss. 8, pp. 582-590
Open Access | Times Cited: 27
Elizabeth A. Cairns, Anna-Maria Szczesniak, Alex Straiker, et al.
Journal of Ocular Pharmacology and Therapeutics (2017) Vol. 33, Iss. 8, pp. 582-590
Open Access | Times Cited: 27
The arguments for and against cannabinoids application in glaucomatous retinopathy
Yunes Panahi, Azadeh Manayi, Marjan Nikan, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 86, pp. 620-627
Closed Access | Times Cited: 25
Yunes Panahi, Azadeh Manayi, Marjan Nikan, et al.
Biomedicine & Pharmacotherapy (2016) Vol. 86, pp. 620-627
Closed Access | Times Cited: 25
Neuroprotective effect of cannabinoid receptor 1 antagonist in the MNU-induced retinal degeneration model
Yuanyuan Chen, Xue Luo, Shiliang Liu, et al.
Experimental Eye Research (2017) Vol. 167, pp. 145-151
Closed Access | Times Cited: 25
Yuanyuan Chen, Xue Luo, Shiliang Liu, et al.
Experimental Eye Research (2017) Vol. 167, pp. 145-151
Closed Access | Times Cited: 25
Cannabinoid-Based Ocular Therapies and Formulations
Sofia M. Saraiva, Lucía Martín‐Banderas, Matilde Durán‐Lobato
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1077-1077
Open Access | Times Cited: 7
Sofia M. Saraiva, Lucía Martín‐Banderas, Matilde Durán‐Lobato
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1077-1077
Open Access | Times Cited: 7
Natural compounds and retinal ganglion cell neuroprotection
Luigi Antonio Morrone, Laura Rombolà, Maria Tiziana Corasaniti, et al.
Progress in brain research (2015), pp. 257-281
Closed Access | Times Cited: 23
Luigi Antonio Morrone, Laura Rombolà, Maria Tiziana Corasaniti, et al.
Progress in brain research (2015), pp. 257-281
Closed Access | Times Cited: 23
The Retina of Osteopontin deficient Mice in Aging
Noelia Ruzafa, Xandra Pereiro, Patricia Aspichueta, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 1, pp. 213-221
Open Access | Times Cited: 22
Noelia Ruzafa, Xandra Pereiro, Patricia Aspichueta, et al.
Molecular Neurobiology (2017) Vol. 55, Iss. 1, pp. 213-221
Open Access | Times Cited: 22
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?
Demetrios Moris, Sotirios Georgopoulos, Evangelos Felekouras, et al.
Expert Opinion on Therapeutic Targets (2015) Vol. 19, Iss. 9, pp. 1261-1275
Closed Access | Times Cited: 17
Demetrios Moris, Sotirios Georgopoulos, Evangelos Felekouras, et al.
Expert Opinion on Therapeutic Targets (2015) Vol. 19, Iss. 9, pp. 1261-1275
Closed Access | Times Cited: 17
CB1R, CB2R and TRPV1 expression and modulation in in vivo, animal glaucoma models: A systematic review
Gabriele Gallo Afflitto, Francesco Aiello, Damiana Scuteri, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112981-112981
Open Access | Times Cited: 9
Gabriele Gallo Afflitto, Francesco Aiello, Damiana Scuteri, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 150, pp. 112981-112981
Open Access | Times Cited: 9
Effect of acute and subchronic administration of (R)-WIN55,212-2 induced neuroprotection and anti inflammatory actions in rat retina: CB1 and CB2 receptor involvement
Dimitris Spyridakos, Sofia Papadogkonaki, Stavroula Dionysopoulou, et al.
Neurochemistry International (2020) Vol. 142, pp. 104907-104907
Closed Access | Times Cited: 14
Dimitris Spyridakos, Sofia Papadogkonaki, Stavroula Dionysopoulou, et al.
Neurochemistry International (2020) Vol. 142, pp. 104907-104907
Closed Access | Times Cited: 14
Neuroprotection of retinal ganglion cells in vivo using the activation of the endogenous cannabinoid signaling system in mammalian eyes
Greg Maguire, Christy Eubanks, George Ayoub
Neuronal Signaling (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 8
Greg Maguire, Christy Eubanks, George Ayoub
Neuronal Signaling (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 8
